Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference54 articles.
1. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis;Oka;Lancet Gastroenterol Hepatol,2020
2. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study;Sperber;Gastroenterology,2021
3. Irritable bowel syndrome;Ford;Lancet,2020
4. Global burden of irritable bowel syndrome: trends, predictions and risk factors;Black;Nat Rev Gastroenterol Hepatol,2020
5. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom;Goodoory;Aliment Pharmacol Ther,2022
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Randomized double‐blind placebo‐controlled study to evaluate the effect of long‐acting mesalamine on postinfectious irritable bowel syndrome with diarrhea;Neurogastroenterology & Motility;2024-08-05
2. Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?;Expert Opinion on Investigational Drugs;2024-04-25
3. Exploring the Contribution of Campylobacter jejuni to Post-Infectious Irritable Bowel Syndrome: A Literature Review;Applied Sciences;2024-04-17
4. Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs;Expert Opinion on Investigational Drugs;2024-02-23
5. Management of Irritable Bowel Syndrome With Diarrhea;Journal of Clinical Gastroenterology;2024-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3